---
title: 'Senior Manager, Biostatistics at Eikon Therapeutics'
canonical: 'https://feeny.ai/job/senior-manager-biostatistics-eikon-therapeutics-jersey-city-cdzwe0z05kpz'
type: 'job'
last_seen: '2026-09-06'
---

# Senior Manager, Biostatistics at Eikon Therapeutics

- **Company:** Eikon Therapeutics
- **Location:** Jersey City, NJ
- **Posted:** 2026-08-10
- **Last confirmed live:** 2026-09-06
- **Apply:** https://job-boards.greenhouse.io/eikontherapeutics/jobs/5208126007

## Job description

Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets.

Position

We are seeking a skilled and highly motivated Senior Manager, Biostatistics to join our talented team. The successful candidate will contribute their statistical expertise and strategic thinking to the design, execution, and analysis of clinical trials and experimental studies. In collaboration with cross-functional teams, you will lead statistical efforts that facilitate evidence-based conclusions and guide our research and development initiatives.

## About You

The ideal candidate for this role should possess a proven track record of designing and analyzing clinical trials and experimental studies, particularly within the biotechnology, pharmaceutical, or related industries. This candidate excels in leading interdisciplinary teams to design studies, developing statistical analysis plans, performing advanced statistical analyses, and providing guidance to team members. Their proficiency in statistical programming languages, understanding of regulatory guidelines, and excellent communication skills are essential for conveying complex statistical concepts to non-technical stakeholders. The ideal candidate also demonstrates leadership capabilities and a deep knowledge of emerging trends and best practices in biostatistics, statistical tools, and software.

This role will require a minimum of 3 day a week of onsite presence (or more as business needs require) in our New Jersey office to ensure effective management, operational excellence and high-performance delivery of clinical studies and to support the expected significant team growth & collaboration.

## What You’ll Do

- Collaborate with interdisciplinary teams to design clinical trials, experiments, and studies, ensuring appropriate statistical methodologies are employed.
- Lead the development of statistical analysis plans, including endpoints, sample size determination, randomization strategies, and statistical methodologies.
- Perform advanced statistical analyses on complex datasets, interpreting results and drawing actionable conclusions.
- Provide guidance and mentorship to biostatisticians and statistical programmers within the team.
- Contribute to regulatory submissions by providing statistical expertise and preparing relevant sections of documents.
- Stay current with emerging trends and best practices in biostatistics and their application in the biotechnology field.
- Drive the implementation and utilization of advanced statistical tools and software.

Qualifications:

- PhD or equivalent degree in statistics/biostatistics or related discipline with a minimum of 3 years of clinical research and drug development experience, or a Master's degree with a minimum of 7 years relevant work experience.
- Deep, hands-on proficiency in R within the Posit/RStudio ecosystem (R Markdown, Shiny, tidyverse).
- Substantial oncology trial experience — familiarity with standard oncology designs and endpoints (RECIST, dose-escalation/optimization designs such as BOIN, biomarker-driven subgroup work).
- Demonstrated ability to independently own the full analysis lifecycle, from raw data through exploratory analysis to finished output.
- Strong understanding of regulatory guidelines (ICH, FDA, etc.) and experience authoring statistical analysis plans and reporting via tables, listings, and figures.
- Experience with Bayesian statistics and adaptive trial designs (e.g., BOIN-type dose-escalation, dose-optimization frameworks).
- Excellent communication skills, including translating statistical findings for non-technical stakeholders.
- Demonstrated leadership capabilities, including the ability to lead and mentor a team.
- Experience contributing statistical analysis to peer-reviewed clinical publications or conference presentations (e.g., trial results manuscripts, oncology conference abstracts and posters).

At Eikon, employee compensation also includes bonus and equity compensation, in addition to several generous benefit programs, including:​

- 401k plan with company matching​
- Medical (premiums covered by Eikon at 95%), dental and vision insurance (premiums covered by Eikon at 100%)​
- Mental health and wellness benefits​
- Weeklong summer and winter holiday shutdowns​
- Generous paid time off and holiday policies​
- Life/AD&D Insurance (premiums covered by Eikon at 100%) and optional supplemental employee-paid life/AD&D policies ​
- Enhanced parental leave benefit​
- Daily subsidized lunch program when on-site​

The expected salary range for this role is $170,000 to $204,750 depending on skills, competency, and the market demand for your expertise. Eikon is proud to be an equal opportunity employer and will consider all qualified applicants for employment.

We are currently not accepting any new third-party agencies or firms at this time. Please do not forward unsolicited agency resumes to our website, employees or Human Resources. Eikon Therapeutics will not pay fees to any third-party agency or firm associated with unsolicited resumes.

## About Eikon Therapeutics

## Company Overview
- **One-liner**: Eikon Therapeutics is a late-stage clinical biopharmaceutical company that integrates single-molecule imaging, machine learning, and engineering to discover and develop novel therapies for oncology, immunology, and neuroscience.
- **Entity Type**: Public (NASDAQ: EIKN) – originally privately held, went public via a post-IPO equity round in 2026.
- **Headquarters**: Millbrae, California, United States
- **Founded**: 2019
- **Founders**: Not publicly named in the search results; the company was seeded by The Column Group.

## Core Business
- **Primary industry**: Biotechnology research and drug development (therapeutics)
- **Target customers**: Patients with unmet medical needs; the company partners with clinical research organizations, healthcare providers, and regulators.
- **Mission or purpose statement**: “Better insights will lead to better medicines” – the company aims to introduce new therapies that improve and extend life by deeply understanding human disease biology.

## Products & Services
- **EIK10 (TLR7/8 agonist)**: Phase 2 clinical program for solid tumors, leveraging immune response modulation.
- **VCP inhibitor (undisclosed target)**: Phase 1 program in oncology.
- **AR-v7 degrader**: Preclinical/early clinical program targeting androgen receptor splice variant in cancer.
- **PARP1 inhibitor**: Early-stage oncology program; also a CNS-penetrant PARP1 candidate for neuroscience.
- **AR degrader**: Preclinical androgen receptor degrader.
- **Discovery-stage programs**: Multiple undisclosed targets in oncology, immunology, and neuroscience, supported by the company’s single-molecule imaging platform.

## Market Standing
- **Valuation/Market Cap**: Not disclosed in search results; total funding of ~$1.5B as of mid-2026.
- **Key Metrics**:
  - Annual Revenue: $5.6M (reflective of early-stage, pre-commercial biotech).
  - Total Funding: $1.5B (seed, Series A $148M in 2021, Series B $518M in 2022, Series C $106M in 2023, and post-IPO equity of $381.2M in 2026).
- **Notable Investors/Partners**: The Column Group (lead seed/Series A), 18 investors in Series B, and multiple institutional partners across rounds; board includes industry veterans (e.g., Roger Perlmutter, former Merck CEO).
- **Growth Signals**:
  - Headcount grew ~2.7% YoY to 314 employees (2025–2026).
  - Active job postings increased 270% year-over-year (as of mid-2026).
  - Expanding pipeline into immunology and neuroscience beyond oncology.
  - Recent $351M financing event (reported by multiple outlets) to fund late-stage trials.

## Competitive Advantages
- **Proprietary single-molecule imaging platform** that enables real-time observation of protein dynamics at the single-molecule level, providing insights into disease mechanisms that traditional methods miss.
- **Machine learning integration** to analyze massive imaging datasets, accelerating target identification and drug design.
- **Deep bench of scientific talent**: Executives include Roger Perlmutter (CEO, ex-Merck), Roy Baynes (CMO, ex-Merck), and a team drawing from Genentech, Bristol Myers Squibb, Pfizer, and top academic institutions.
- **Cross-disciplinary approach** merging biology, engineering, and computation under one roof, reducing the “translation gap” between discovery and clinic.

## Strategic Focus
- **Advancing late-stage oncology pipeline**: Lead program (TLR7/8 agonist) in Phase 2, with plans to move into pivotal trials.
- **Expanding into new therapeutic areas**: Significant preclinical investment in immunology and neuroscience, with CNS-penetrant PARP1 and AR programs.
- **Continued platform development**: Scaling imaging and machine learning capabilities to enable faster, more precise drug discovery across multiple indications.
- **Building commercial infrastructure**: Post-IPO financing supports preparation for potential product launches and expanded clinical operations.

## Why Work Here
- **Culture**: Values-driven environment prioritizing execution, collaboration, innovation, transparency, respect, and caring for patients and colleagues.
- **Engineering & science fusion**: Opportunity to work at the intersection of advanced imaging, machine learning, and drug development – unique in biotech.
- **Growth trajectory**: Young company with strong funding, public listing, and rapidly expanding pipeline; employees can have significant impact.
- **Compensation**: Competitive base salaries (e.g., Software Engineer ~$140k, Senior Software Engineer ~$167k) plus equity incentives.
- **Work model**: Likely office-based at the Millbrae HQ or satellite labs in Hayward, CA; clinical roles may require travel; no explicit remote/hybrid policy in search results.
- **Perks**: Not detailed, but typical biotech benefits (health, 401k, PTO) are assumed; the company emphasizes a “transparent and inclusive culture” per its values.
- **Employee sentiment**: Overall rating 3.0/5 on LinkedIn (66 reviews); work-life balance 3.2, compensation 3.4, culture 3.0, career opportunities 2.9 – indicating room for improvement in career development.

## Sources
1. [eikontx.com](https://www.eikontx.com/)
2. [eikontx.com/about-us](https://www.eikontx.com/about-us/)
3. [eikontx.com/join-us](https://www.eikontx.com/join-us/)
4. [eikontx.com/pipeline](https://www.eikontx.com/pipeline/)
5. [linkedin.com/company/eikon-therapeutics-inc](https://www.linkedin.com/company/eikon-therapeutics-inc)

## Other roles at Eikon Therapeutics

- [Associate Director, Clinical Regulatory](https://feeny.ai/job/associate-director-clinical-regulatory-eikon-therapeutics-jersey-city-k85gtnexs2a1) — Jersey City, NJ
- [Senior Clinical Trial Manager, Oncology (APAC)](https://feeny.ai/job/senior-clinical-trial-manager-oncology-apac-eikon-therapeutics-jersey-city-vq62tce7x87v) — Jersey City, NJ / Millbrae, CA
- [Senior Director, Clinical Research (Medical Director)](https://feeny.ai/job/senior-director-clinical-research-medical-director-eikon-therapeutics-jersey-mcxrw0kk581x) — Jersey City, NJ
- [Staff Software Engineer, Machine Learning and Computational Chemistry](https://feeny.ai/job/staff-software-engineer-machine-learning-and-computational-chemistry-eikon-202k9e76vmy5) — Millbrae, CA
- [Sr. Director, Regulatory Affairs](https://feeny.ai/job/sr-director-regulatory-affairs-eikon-therapeutics-jersey-city-jkyatykrntds) — Jersey City, NJ
- [Senior Director, Total Rewards](https://feeny.ai/job/senior-director-total-rewards-eikon-therapeutics-millbrae-550rjqcker3j) — Millbrae, CA
- [Senior Informatics Engineer](https://feeny.ai/job/senior-informatics-engineer-eikon-therapeutics-millbrae-2g6dsjx5a73z) — Millbrae, CA
- [Senior Clinical Quality Operations Manager](https://feeny.ai/job/senior-clinical-quality-operations-manager-eikon-therapeutics-jersey-city-cktq0jdk1mn1) — Jersey City, NJ / Millbrae, CA
- [Senior Clinical Trial Manager, Oncology](https://feeny.ai/job/senior-clinical-trial-manager-oncology-eikon-therapeutics-millbrae-f90cz419kkaf) — Millbrae, CA / Jersey City, NJ
- [Senior Scientist, Analytical CMC](https://feeny.ai/job/senior-scientist-analytical-cmc-eikon-therapeutics-millbrae-y03yk2c2hwv6) — Millbrae, CA